An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 6, 2010, Pages 1195-1206

  Hill, Katja E ^a,b   Malic, Sladjana ^a   McKee, Ruth ^a,b   Rennison, Tracy ^c   Harding, Keith G ^b   Williams, David W ^a   Thomas, David W ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Department of Wound Healing ^*  (United Kingdom)

^c ETHICON INC   (United States)

Author keywords

Antibiotic Resistance; Biocide resistance; Chronic venous leg ulcer; Coaggregation; Constant depth film fermenter; Lactoferrin

Indexed keywords

ACTICOAT; ACTISORB; ALGINIC ACID; ANTIBIOTIC AGENT; AQUACEL; CIPROFLOXACIN; CONTREET; FLUCLOXACILLIN; INADINE; IODINE; IODOFLEX; LACTOFERRIN; METICILLIN; NUDERM; POVIDONE IODINE; SILVER; SILVERCEL; UNCLASSIFIED DRUG;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTEROIDES FRAGILIS; BIOFILM; BIOREACTOR; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EGGERTHELLA LENTA; GRANULICATELLA ADIACENS; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROCOCCUS; MICROCOCCUS LUTEUS; MICROMONAS; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTOSTREPTOCOCCUS; PHENOTYPE; PRESCRIPTION; PROPIONIBACTERIUM ACNES; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS ORALIS; WOUND DRESSING;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIA; BANDAGES; BIOFILMS; CIPROFLOXACIN; FLOXACILLIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MICROSCOPY, ELECTRON, SCANNING; POVIDONE-IODINE; PSEUDOMONAS; SILVER; STAPHYLOCOCCUS; WOUND INFECTION;

EID: 77953484769     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq105     Document Type: Article

References (64)

1. Price LB, Liu CM, Melendez JH et al. Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. PLoS ONE 2009; 4: e6462.
2. Stephens P, Wall IB, Wilson MJ et al. Anaerobic cocci populating the deep tissues of chronic wounds impair cellular wound healing responses in vitro. Brit J Dermatol 2003; 148: 1-11.
3. Wall I, Davies CE, Hill K et al. Potential role of anaerobic cocci in impaired human wound healing. Wound Repair Regen 2002; 10: 346-53.
4. 5 bacterial growth guideline: reassessing its clinical relevance in wound healing. Ostomy Wound Manage 2003; 49: 44-53.
5. Davies CE, Hill KE, Stephens P et al. A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs. Wound Rep Regen 2007; 15: 17-22.
6. Trengove NJ, Stacey MC, McGechie DF et al. Qualitative bacteriology and leg ulcer healing. J Wound Care 1996; 5: 277-80.
7. Bowler PG, Davies BJ. The microbiology of infected and non-infected leg ulcers. Int J Dermatol 1999; 38: 573-8.
8. Brook I, Frazier EH. Aerobic and anaerobic microbiology of chronic venous ulcers. Int J Dermatol 1998; 37: 426-8.
9. Hansson C, Holborn J, Moller A et al. The microbial flora in venous leg ulcers without clinical signs of infection. Acta Derm Venereol 1995; 5: 24-30.
10. Howell-Jones RS, Wilson MJ, Hill KE et al. A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 2005; 55: 143-9.
11. Howell-Jones RS, Price PE, Howard AJ et al. Antibiotic prescribing for chronic skin wounds in primary care. Wound Repair Regen 2006; 14: 387-93.
12. Bjarnsholt T, Kirkterp-Møller K, Jensen PØ et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008; 16: 2-10.
13. Davis SC, Ricotti C, Cazzaniga A et al. Microscopic and physiologic evidence for biofilm-associated wound colonisation in vivo. Wound Repair Regen 2008; 16:23-9.
14. Percival SL, Bowler P, Woods EJ. Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Rep Regen 2008; 16: 52-7.
15. Percival SL, Bowler PG. Biofilms and their potential role in wound healing. Wounds 2004; 16: 234-40.
16. Mertz PM. Cutaneous biofilms: friend or foe? Wounds 2003; 15: 129-32.
17. Percival SL, Rogers AA. The significance and role of biofilms in chronic wounds. In: Macbain A, Allison A, Pratten J et al., eds. Biofilms: Persistence and Ubiquity. Manchester, UK: The Biofilm Club, University of Manchester, 2005; 171-9.
18. Serralta VW, Harrison-Balestra C, Cazzangia AL. Lifestyles of bacteria in wounds: presence of biofilms? Wounds 2001; 13: 29-34.
19. Harrison-Balestra C, Cazzaniga AL, Davis SC et al. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualised by light microscopy. Dermatol Surg 2003; 29: 631-5.
20. Malic S, Hill KE, Hayes A et al. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid (PNA) fluorescent in situ hybridisation (FISH). Microbiol 2009; 155: 2603-11.
21. Rickard AH, Gilbert P, Handley PS. Influence of growth environment on coaggregation between freshwater biofilm bacteria. J Appl Microbiol 2004; 96: 1367-73.
22. Rickard AH, Leach SA, Buswell CM et al. Coaggregation between aquatic bacteria is mediated by specific-growth-phase-dependent lectin-saccharide interactions. Appl Environ Microbiol 2000; 66: 431-4.
23. Rickard AH, McBain AJ, Ledder RG et al. Coaggregation between freshwater bacteria within biofilm and planktonic communities. FEMS Microbiol Lett 2003; 220: 133-40.
24. Bradshaw DJ, Marsh PD, Watson GK et al. Role of Fusobacterium nucleatum and coaggregation in anaerobe survival in planktonic and biofilm oral microbial communities during aeration. Infect Immun 1998; 66: 4729-32.
25. Drago L, Gismondo MR, Lombardi A et al. Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol Lett 1997; 153: 455-63.
26. Kmet V, Lucchini F. Aggregation-promoting factor in human vaginal Lactobacillus strains. FEMS Immunol Med Microbiol 1997; 19: 111-4.
27. Reid G, McGroarty JA, Angotti R et al. Lactobacillus inhibitor production against Escherichia coli and coaggregation ability with uropathogens. Can J Microbiol 1988; 34: 344-51.
28. Vandevoorde L, Christiaens H, Verstraete W. Prevalence of coaggregation reactions among chicken lactobacilli. J App Bacteriol 1992; 173: 697-703.
29. Buswell CM, Herlihy YM, Marsh PD et al. Coaggregation amongst aquatic biofilm bacteria. J Appl Microbiol 1997; 83: 477-84.
30. Malik A, Sakamoto M, Hanazaki S et al. Coaggregation among non-flocculating bacteria isolated from activated sludge. Appl Environ Microbiol 2003; 69: 6056-63.
31. Norwood DE, Gilmour A. The growth and resistance to sodium hypochlorite of Listeria monocytogenes in a steady-state multispecies biofilm. J Appl Microbiol 2000; 88: 512-20.
32. Kinniment SL, Wimpenny JW, Adams D et al. Development of a steady-state oral microbial biofilm community using the constantdepth film fermenter. Microbiol 1996; 142: 631-8.
33. McBain AJ, Bartolo RG, Catrenich CE et al. Microbial characterization of biofilms in domestic drains and the establishment of stable biofilm microcosms. Appl Environ Microbiol 2003; 69: 177-85.
34. Wilson M. Use of the constant depth film fermenter in studies of biofilms of oral bacteria. Methods Enzymol 1999; 310: 264-96.
35. Pratten J, Wilson M. Antimicrobial susceptibility and composition of microcosm dental plaques supplemented with sucrose. Antimicrob Agents Chemother 1999; 43: 1595-9.
36. Vroom JM, de Grauw KJ, Gerritsen HC et al. Depth penetration and detection of pH gradients in biofilms by two-photon excitation microscopy. Appl Environ Microbiol 1999; 65: 3502-11.
37. Deng DM, Buijs MJ, ten Cate JM. The effects of substratum on the pH response of Streptococcus mutans biofilms and on the susceptibility to 0.2% chlorhexidine. Eur J Oral Sci 2004; 112:42-7.
38. Mulligan AM, Wilson M, Knowles JC. Effect of increasing silver content in phosphate-based glasses on biofilms of Streptococcus sanguis. J Biomed Mater Res Part A 2003; 67A: 401-12.
39. Ready D, Roberts AP, Pratten J et al. Composition and antibiotic resistance profile of microcosm dental plaques before and after exposure to tetracycline. J Antimicrob Chemother 2002; 49: 769-75.
40. Davies CE, Hill KE, Wilson MJ et al. Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and non-healing chronic venous leg ulcers. J Clin Microbiol 2004; 42: 3549-57.
41. Hill KE, Davies CE, Wilson MJ et al. Molecular analysis of the microflora of chronic venous leg ulceration. J Med Microbiol 2003; 52: 365-9.
42. Kinder SA, Holt SC. Coaggregation between bacterial species. Methods Enzymol 1994; 236: 254-70.
43. Kolenbrander PE, Andersen RN, Clemens DL et al. Potential role of functionally similar coaggregation mediators in bacterial succession. In: Newman HN, Wilson M, eds. Dental Plaque Revisited: Oral Biofilms in Health and Disease. Cardiff, UK: Bioline, Cardiff University, 1999; 171-86.
44. Rosen G, Sela MN. Coaggregation of Porphyromonas gingivalis and Fusobacterium nucleatum PK1594 is mediated by capsular polysaccharide and lipopolysaccharide. FEMS Microbiol Lett 2006; 256: 304-10.
45. McKee AS, McDermid AS, Ellwood DC et al. The establishment of reproducible, complex communities of oral bacteria in the chemostat using defined inocula. J Appl Bacteriol 1985; 59: 263-75.
46. Cisar JO, Kolenbrander PE, McIntire FC. Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii. Infect Immun 1979; 24: 742-52.
47. Jorgensen JH, Turnidge JD, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA et al., eds. Manual of Clinical Microbiology. 7th edn. Washington, DC: American Society for Microbiology, 1999; 1526-43.
48. British National Formulary Vol. 56. British Medical Association and The Royal Pharmaceutical Society of Great Britain. London, UK: BMJ Publishing Group Ltd and RPS Publishing, 2008.
49. Micromedex Healthcare Series. 120: Thomson Healthcare, Greenwood Village, CO, 2004.
50. Bradshaw DJ, Marsh PD, Watson GK et al. Oral anaerobes cannot survive oxygen stress without interacting with facultative/aerobic species as a microbial community. Lett Appl Microbiol 1997; 25: 385-7.
51. Sun Y, Smith E, Wolcott R et al. Propagation of anaerobic bacteria within an aerobic multi-species chronic wound biofilm model. J Wound Care 2009; 18: 426-31.
52. Hoyle BD, Costerton WJ. Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res 1991; 37: 91-105.
53. Mah TF, Pitts B, Pellock B et al. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003; 426: 306-10.
54. Walters MC, Roe F, Bugnicourt A et al. Contributions of antibiotic penetration, oxygen limitation and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 2003; 47: 317-23.
55. Borriello G, Werner E, Roe F et al. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 2004; 48: 2659-64.
56. Kropec A, Daschner FD. Penetration into tissues of various drugs active against gram-positive bacteria. J Antimicrob Chemother 1991; 27 SUPPL B: 9-15.
57. Percival SL, Bowler PG, Dolman J. Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J 2007; 4: 186-91.
58. Sibbald RG, Contreras-Ruiz J, Coutts P et al. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers. Adv Skin Wound Care 2007; 20: 549-58.
59. Walker M, Bowler PG, Cochrane CA. In vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products. Ostomy Wound Manage 2007; 53: 18-25.
60. Bjarnsholt T, Kirkterp-Møller K, Kristiansen S et al. Silver against Pseudomonas aeruginosa biofilms. APMIS 2007; 115: 921-8.
61. Thomas S, McCubbin P. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care 2003; 12: 101-7.
62. Singh PK, Parsek M, Greenberg EP et al. A component of innate immunity prevents bacterial biofilm development. Nature 2002; 417: 552-5.
63. Caraher EM, Gumulapurapu K, Taggart CC et al. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms. J Antimicrob Chemother 2007; 60: 546-54.
64. Psaltis AJ, Wormald PJ, Ha KR et al. Reduced levels of lactoferrin in biofilm-associated chronic rhinosinusitis. Laryngoscope 2008; 118: 895-901.